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 Introduction 
 Abdominal wall defects resulting from trauma or in-
cisional hernias are difficult to close for general surgeons 
and plastic surgeons. The prevalence is up to 10% of all 
laparatomies and these defects cause mechanical and 
physiological disturbances that increase patient morbid-
ity. Small hernia repair by primary closure with suture 
has been associated with recurrence rates of up to 63% in 
a 7-year median follow-up. The introduction of mesh has 
resulted in a decrease of recurrence rates to approximate-
ly 30%, with most of the recurrences occurring within the 
1st year after repair  [1] . Various methods and materials 
for treatment are described, such as synthetic materials 
like polytetrafluorethylene (PTFE)  [2] or polypropylene 
mesh  [3] . The disadvantage of these materials can be the 
formation of fibrosis and abdominal adhesions  [4] . In ad-
dition, a higher risk of infection is associated with syn-
thetic materials.
 In patients with comorbidity such as morbid obesity, 
diabetes and or a history of infection, complications such 
as mesh extrusion, infection and fistula formation have 
been reported ranging from 23 to 78%  [5] . Plastic sur-
geons have developed techniques to allow hernia closure 
by autologous tissue mobilization without the use of pros-
thetic materials, which are prone to infection and fistula 
formation. These techniques involve medial mobilization 
of the abdominal rectus muscles either with or without 
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 Abstract 
 Background: Abdominal wall repair can be performed with 
synthetic or biological materials. Biological materials may re-
duce the risk of infections and fibrosis. The aim of this study 
was to evaluate two acellular human dermis products.  Ma-
terials and Methods: A rat model was used to compare the 
two materials. One was prepared using low concentrations 
of NaOH; the other material was SureDerm TM , which is com-
mercially available. Full thickness defects were prepared in 
the abdominal wall and closed with the materials. Rats were 
sacrificed at 1 or 4 months after operation and the numbers 
of adhesions to the bowels were scored. Samples were tak-
en for histological analysis and to measure the breaking 
strength.  Results: In both groups a good functional integra-
tion of the implants with the abdominal wall was observed. 
There was no adhesion formation with the bowels in the 
group with the NaOH prototype. In the SureDerm group, 4 
out of 7 rats showed only small adhesions at 4 months after 
operation. Breaking strength of the healed tissue was sig-
nificantly higher in the NaOH prototype group at 4 months 
after operation (p  ! 0.0026).  Conclusions: The results indi-
cate that both human acellular dermis products may be used 
in clinical trials for closure of abdominal wall defects. 
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separation of the components of the abdominal wall  [6] 
or distant or free tissue transfer  [7] . These techniques are 
also associated with recurrence rates of up to 30%.
 The use of biological materials together with these 
techniques may reduce recurrence and associated comor-
bidity. Positive results are reported using human tissue 
such as dura mater  [8] , amniotic membrane  [9] , dermis 
or xenogeneic materials (porcine submucosa, bovine 
pericardium, porcine dermis)  [10] . Recent studies showed 
favorable results using human acellular dermis in animal 
models as well as in patients (ADM  [11] and AlloDerm 
 [12, 13] ).
 The aim of our study was to evaluate the effectiveness 
of two other types of human acellular dermis to close ab-
dominal wall defects. Acellular dermis was prepared 
from human donor skin using two different methods to 
remove the donor cells and antigenic structures. One 
prototype developed by our research group is intended to 
ensure the integrity of the collagen elastin matrix and is 
reproducible without the use of expensive techniques 
and/or storage methods. The other acellular human der-
mis type is SureDerm TM , which is commercially available 
(Hans Biomed, Seoul, Korea). Both types were tested as 
implants to repair full thickness defects in the abdominal 
wall of rats. The incidence of adhesion formation, in-
flammatory response and the tensile strength was com-
pared at 1 and at 4 months after operation.
 Materials and Methods 
 Preparation of the Implants 
 Donor dermal tissue was recovered with a dermatome from a 
donor (deceased person who gave informed consent) after the re-
moval of the first layer of skin with the epidermis. Thickness of 
this second layer of dermis was 0.8–1 mm. Donor dermal cells 
were removed using two different methods. With one method, the 
dermis was incubated in 0.06  N NaOH at room temperature for 6 
weeks with shaking at regular intervals. The NaOH solution was 
replaced every week. After 6 weeks, the NaOH solution was neu-
tralized using HCl and the tissue washed with 0.9% NaCl. This 
NaOH prototype acellular dermis was then stored in 85% glyc-
erol until use in the rat experimental model. Processing in glyc-
erol 85% of the material can be done without any effects on the 
structural integrity, and the glycerol has antibacterial and viru-
cidal properties  [14, 15] .
 The other material is produced according to a patent of Hans 
Biomed, the product SureDerm, a human acellular dermis for soft 
tissue repair. The material is prepared using enzymes and EDTA. 
Thereafter the material is freeze-dried and can be stored at 4–
8 ° C. For the experiments, the type of SureDerm for implant was 
used, with a thickness of 0.8–1 mm. This was obtained from Hans 
Biomed.
 Samples of both materials were taken for histology to assess 
the integrity of the collagen and elastin matrix. Hematoxylin and 
eosin and Elastica van Gieson staining were used.
 Rat Model 
 Twenty-eight rats were used (male Wistar, 180–200 g) ob-
tained from Harlan-CPB (Zeist, The Netherlands). The local ani-
mal welfare committee of the VU Medical Centre approved the 
research protocol. The rats were kept under routine laboratory 
conditions with free access to food and water. They were kept in 
separate cages for 2 weeks after surgery.
 Rats were anesthetized using a mixture of N 2 /O 2 /isoflurane. 
A full thickness defect down to peritoneal cavity in the abdominal 
wall of 1 by 1.5 cm was created, which was repaired using the 
NaOH prototype as implant in 14 of the animals. SureDerm was 
used in the other group of 14 animals. Both materials were rinsed 
in 0.9% NaCl before use and then sutured with PDS II (Ethicon, 
Johnson & Johnson, Brussels, Belgium) to the defect with mini-
mal tension. The skin was sutured with vicryl 3/0 (Ethicon, John-
son & Johnson). Postoperative pain control was achieved with 
Temgesic (buprenorphine hydrochloride, 0.03 mg/kg rat) injected 
intramuscularly directly after the operation.
 In both groups, 7 animals were sacrificed after 1 month, the 
other 7 animals at 4 months after operation. The abdominal cav-
ity was opened carefully to score the presence of adhesions to the 
implants. Digital images were taken with a camera; these were 
used to estimate the size of the implants. Settings of the camera 
were the same for all animals. The animals were placed on a board 
of 15 by 25 cm and fixed at 4 points, always in the same way. The 
pictures were taken in such a way that the board was included to 
allow measurements. Thereafter, biopsies of the implants includ-
ing abdominal wall without the skin were taken for histological 
analysis.
 Biopsies for measuring breaking force were prepared only 
from the animals in the groups that were sacrificed at 4 months 
after operation. At this time point, the PDS sutures had been re-
sorbed.
 Immuno(histo)chemistry 
 Half of the samples were fixed in Kryofix and embedded in 
paraffin for routine hematoxylin-eosin staining. Hematoxylin 
and eosin were obtained from Gurr (BDH, Poole, UK). Sections 
were fixed in Baker’s formalin before staining.
 The other samples were frozen in liquid nitrogen. Cryosec-
tions were prepared to perform specific staining for rat macro-
phages using the ED-2 monoclonal antibody  [16] . After fixation 
in acetone, slides were incubated with the primary antibody for 
45 min at room temperature. Thereafter the slides were washed 3 
times with PBS followed by incubation with a biotinylated sec-
ondary antibody (rabbit anti-mouse, Dako, Glostrup, Denmark) 
for 1 h at room temperature. After washing with PBS, slides were 
incubated with alkaline phosphatase-conjugated streptavidin 
(Vector, Burlingame, Calif., USA). Positive staining was then vi-
sualized by using alkaline phosphatase substrate containing 
naphthol AS-BI phosphate (Sigma, St. Louis, USA) and new fuch-
sin (Gurr) resulting in red staining. 1 m M levamisole (Sigma) was 
added to the substrate to block endogenous activity.
 Two independent observers analyzed the stained sections. The 
numbers of positive cells (ED-2-positive macrophages)/mm 2 of 
tissue were counted using a grid measuring 1 mm 2 (10 by 10 fields) 
 Pirayesh /Dur /Paauw /Monstrey /Kreis /
Hoekstra /Richters 
Eur Surg Res 2008;41:346–352348
in the ocular of the microscope. Five regions per section were 
counted, 2 were randomly selected on the border of the matrix 
implant, 3 in the center.
 Tensile Load Testing 
 Tensile strength measurement was performed on a tensiome-
ter (Instron 8872). Strips of tissue (width 1 cm) comprised the 
implant with 2 cm abdominal wall tissue without the skin. They 
were cut at both sides using a device with fixed knives. This device 
is a plastic block with 3 blades placed at a distance of 1 cm. By us-
ing this device, strips of tissue of the same size could be obtained. 
Stretching velocity was 2 cm/min.
 Statistical Analysis 
 The   2 test was used to analyze the adhesion formation data. 
The unpaired t test (two-tailed) was used to compare the results 
of the number of macrophages in the implants and the tensile 
strength.
 Results 
 Adhesion Formation 
 Animals were checked daily for local or systemic com-
plications. None of the rats suffered from infection or 
other complications related to the implants. They were 
euthanized at 1 and 4 months after the operation, and
the presence of adhesions was scored. All rats had mild 
adhesion of the omentum to the borders of the implants. 
The group with the NaOH prototype implant had no ad-
hesions of the intestines whereas in the group with the 
SureDerm implant, 4 out of 7 (after 1 month) or 3 out of 
7 rats (after 4 months) showed adhesion of the small bow-
el to the implant ( table 1 ). Although this is a significant 
(p = 0.018 and 0.051) difference, these adhesions were 
only mild adhesions, as shown in  figure 1 , which were 
limited to one area. In addition, we observed in some rats 
adhesions of the implant to the skin, especially in the 
group with the NaOH prototype implant (3 out of 7 rats 
at 1 month, p = 0.051). None of the rats in the group with 
this implant showed adhesion to the skin at 4 months af-
ter operation and only 1 rat of the SureDerm group (not 
significant, p = 0.299). No signs of seroma adhesion could 
be observed in the rats with adhesions to the skin.
 Histopathology Results 
 The sections of both materials before implantation 
showed intact collagen and elastin fibers. Although treat-
ment with NaOH is a stringent method, the low concen-
tration used to obtain the prototype did not result in 
damage to the matrix as shown earlier  [17] .
 Good integration of the implant with the abdominal 
wall was observed in all rats, at 1 month after operation 
as well as in rats 4 months after operation. A fibrous col-
lagen layer was present, connecting the implant with the 
wall ( fig. 2 ). This layer covered the implants; some blood 
vessels were growing from the layer into the implant. The 
human-derived collagen of the implants could be easily 
distinguished from new rat collagen; the implant fibers 
are thicker and larger.
 In none of the rats, relatively short fibers could be ob-
served indicating that new collagen deposition in the im-
plants had not taken place. The implant-derived collagen 
was still in situ after 4 months in the NaOH prototype 
group but there were no signs of replacement by host col-
lagen. No clear signs of contraction of the implants could 
be observed. The implant was partly absorbed (as esti-
mated from the digital pictures, up to 40% reduction of 
the original thickness) in 4 out of 7 rats (range 0–40%) in 
the SureDerm group.
Table 1. Number of rats showing adhesions (n = 7 in each group)
NaOH prototype SureDerm p value
1 month Bowel 0 4 0.018
Skin 3 0 0.051
4 months Bowel 0 3 0.051
Skin 0 1 0.018
 Fig. 1. Example of mild adhesion formation of the small bowel to 
the SureDerm implant 4 months after operation. The omentum 
also shows some adhesion to the implant. 
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 Inflammatory cells (mostly mononuclear cells) were 
observed around sutures but also in the implant. More 
cells were observed in the SureDerm implants compared 
to the NaOH implants ( fig. 3 ). Specific staining for mac-
rophages (ED-2) showed that these cells were present in 
the implants ( fig. 4 ); the number of cells was significant-
ly higher in the SureDerm implants ( fig. 5 ).
 Blood vessels and fibroblasts were also present in the 
implants; higher numbers (up to 2–3 times higher) were 
observed in the SureDerm implants. In the NaOH im-
plants, some calcification was observed around the area 
with sutures.
a b
 Fig. 2. HE-stained sections of the implants. A strong connection between abdominal wall and implant was 
formed both in the group treated with the NaOH prototype ( a ) as well as in the SureDerm group ( b ) 4 months 
after surgery. 
a
 Fig. 3. HE-stained sections of the implants 4 months after surgery. More inflammatory cells are present in Sure-
Derm ( b ) compared to the NaOH prototype ( a ). 
b
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 Tensile Strength 
 At 4 months after the operation, the NaOH implant 
showed a higher tensile strength compared to the Sure-
Derm implant ( fig. 6 ); this was a statistically significant 
difference (p  ! 0.0026, unpaired t test). The strips of tis-
sue tore at the border of the implants in the fibrous tissue 
between the implant and the tissue.
 Discussion 
 Incisional hernia is a common problem encountered 
by surgeons in numerous subspecialties. Repairs that use 
mesh prosthesis are associated with lower recurrence 
rates.
a b
 Fig. 4. Sections of the implants stained with the ED-2 antibody, recognizing rat macrophages (red cells). More 
cells are present in SureDerm ( b ) compared to the NaOH prototype ( a ) 4 months after surgery. 
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 Fig. 5. The number of ED-2-positive macrophages is higher in the 
SureDerm implants 4 months after operation (mean 54.8  8 8.5) 
compared to the NaOH implants (mean 20.5  8 6.1). There is a 
significant difference (p  ! 0.0001). Data are expressed as the mean 
number of cells/mm 2 ( 8 SD) of 7 rats for each type of implant. 
 Fig. 6. The breaking strength of the healed tissue is higher in rats 
treated with the NaOH prototype implants (mean 20  8 4.7) com-
pared to rats with the SureDerm implants (mean 12  8 3.5) 4 
months after surgery. There is a significant difference (p  ! 0.0026). 
Data shown are mean  8 SD with 7 animals in each group. 
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 The use of mesh material with more favorable proper-
ties than traditional mesh in abdominal wall reconstruc-
tion could have a positive impact on surgical practice and 
patient outcomes. The ideal biomaterial would resist in-
fection immediately after implantation, become com-
pletely remodeled into host tissue with mechanical and 
biological properties identical to those of the missing tis-
sue, become rapidly revascularized and infiltrated with 
cells, resist seroma formation, and maintain its original 
strength and surface area during remodeling to prevent 
bulge, failure, or stretch. This ideal material has yet to be 
discovered or produced. Fortunately, certain biopros-
thetic mesh materials have properties that may make 
them closer to this ideal than traditional meshes.
 In the present study, we have compared two proto-
types of biomaterials to close abdominal wall defects in a 
rat model. These biomaterials were derived from human 
donor skin by different methods, an NaOH-treated pro-
totype implant and a commercially available dermis 
(SureDerm). Both types of human donor skin-derived 
implants can be successfully used in the rat model. There 
was a good integration of the implant with the abdominal 
wall at 4 months after operation. None of the rats had 
complications such as infection or incisional hernia. Only 
mild adhesions to the omentum were formed in all rats 
and in some of the rats in the SureDerm group, mild ad-
hesions to the small bowel were observed. The NaOH 
prototype induced adhesions to the skin in some of the 
rats at 1 month after operation but at 4 months only 1 rat 
of the SureDerm group showed adhesion to the skin. 
These are favorable results if compared to results in rats 
using 2  ! 3 polypropylene mesh or PTFE with polypro-
pylene mesh. Demir et al.  [18] reported thick adhesions 
involving more than 50% of the material in most of the 
rats. We observed some adhesions of the materials to the 
skin without a clear explanation; this is still under inves-
tigation.
 It has already been shown in animal models that Al-
loDerm can be successfully used for abdominal wall re-
constructions  [13] . It can be safely used in patients for 
abdominal wall repair  [12] but the material is expensive. 
In this respect, Schuster et al.  [19] advised to use Allo-
Derm only if wound closure with skin can be achieved 
during operation. AlloDerm is an acellular dermal ma-
trix derived from human donor skin  [20] . It is prepared 
using a patented procedure by LifeCell. The results of our 
rat study indicate that other types of acellular dermal ma-
trix obtained by different methods may be used with the 
same optimal functional results.
 Incubation of human skin with low concentrations of 
NaOH is a simple and cost-effective method to remove 
donor cells and hairs. A prototype derived from the up-
per dermal layer of the skin with this method  [17, 21] can 
also be used to improve scar quality and to reduce con-
traction in burn wounds when placed underneath an au-
tologous split skin graft and is currently undergoing 
phase III clinical assessment. The method to obtain Sure-
Derm is a patented procedure of Hans Biomed and the 
product can be ordered for clinical use, for instance 
burns. So far there have been no reports of the use of this 
material in abdominal wall repair. Although the func-
tional results are good for both materials in our rat mod-
el, we observed some differences. In the SureDerm im-
plants, more of the material was resorbed at 4 months 
after operation; this was observed in 4 out of 7 rats. Most 
probably, this is due to the significantly higher number of 
inflammatory cells (predominantly macrophages) that 
were present in the SureDerm implants. The NaOH 
method may be more stringent compared to the method 
to obtain SureDerm, leaving fewer antigenic structures in 
the implants that can induce an inflammatory response. 
The lower breaking strength of SureDerm is most likely 
the result of this resorption of the material by macro-
phages.
 We observed that on both materials, a well-organized 
collagen layer was formed, connecting the abdominal 
wall with the implant and as a parallel layer on the im-
plant covering it. This resulted in a functional closure of 
the defects without complications in most of the rats in-
dicating that the materials are suitable for use in patients. 
We did not observe any replacement of the collagen of the 
implant by new collagen produced by host fibroblast in-
filtrating the implant. This is in agreement with the re-
sults of Zheng et al.  [10] ; they described in a study on 
porcine dermal collagen in rats that the implant also be-
came encapsulated rather than replaced by new tissue. 
This may be due to the xenogeneic origin of the implants. 
The human skin is made acellular and induces only a lim-
ited inflammatory response. The structures of the extra-
cellular matrix molecules may differ from rat molecules 
in such way that collagen production is not induced in the 
rat fibroblasts. In future experiments, we will study the 
materials in large animals such as pigs and in an alloge-
neic setting, i.e. porcine skin treated with NaOH or with 
the SureDerm method before proceeding with a clinical 
study.
 Bioprosthetic materials have increasingly become the 
subject of clinical and scientific interest, and their clinical 
use for abdominal wall reconstruction has increased over 
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the last years with impressive results, particularly in ad-
verse situations. However, a considerable amount of in-
formation has not yet been elucidated or quantified with 
respect to the biological and physiological mechanism of 
action and long-term outcomes of abdominal wall recon-
struction with bioprosthetic materials. The indications 
and contraindications for their use have not been defined 
clearly and likely will become clearer with continued ba-
sic science studies and clinical outcome data. Additional 
evidence-based study data will allow modifications of ex-
isting materials and introduction of new products with 
superior properties and function, which will enhance 
management of abdominal wall defects.
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